日本語 
Pharma
Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services have announced a collaboration that is basically aimed at one thing. Making antibody-drug conjugate work move faster from early development to actual commercial…
Verified Clinical Trials launches in Japan to curb duplicates
Verified Clinical Trials (VCT) is now operating in Japan. They teamed up…
Chugai and Gero Join Forces on Aging Disease Therapies
Chugai Pharmaceutical Co., Ltd. and Singapore-based biotechnology firm Gero PTE. LTD. Gero…
Elix and LINC Unveil AI Drug Platform Using Pharma Data
Elix Inc. and the Life Intelligence Consortium (LINC), a general incorporated association…
Actair® Promotion in Japan Transitions to CEOLIA Pharma
Stallergenes Greer, together with Shionogi & Co., Ltd. and CEOLIA Pharma Co.,…
Alpha Fusion, Curadh MTR Partner on Astatine-211 Drugs
Alpha Fusion, Inc. and Curadh MTR, Inc. They plan to create a…
PHC secures exclusive rights to MaxCyte ExPERT in Japan
The Biomedical Division of PHC Corporation, a subsidiary of PHC Holdings Corporation…
PRD Therapeutics Begins First Human Trial for PRD001
PRD Therapeutics Inc. has announced a first-in-human clinical trial for PRD001. This is…
Axcelead, A2 Healthcare Unite for Pharma R\&D in Japan
Axcelead, Inc., A2 Healthcare Corporation and another company have formed a partnership.…
Verified Clinical Trials launches in Japan to curb duplicates
Verified Clinical Trials (VCT) is now operating in Japan. They teamed up…
Chugai and Gero Join Forces on Aging Disease Therapies
Chugai Pharmaceutical Co., Ltd. and Singapore-based biotechnology firm Gero PTE. LTD. Gero…
Elix and LINC Unveil AI Drug Platform Using Pharma Data
Elix Inc. and the Life Intelligence Consortium (LINC), a general incorporated association…
Actair® Promotion in Japan Transitions to CEOLIA Pharma
Stallergenes Greer, together with Shionogi & Co., Ltd. and CEOLIA Pharma Co.,…
Alpha Fusion, Curadh MTR Partner on Astatine-211 Drugs
Alpha Fusion, Inc. and Curadh MTR, Inc. They plan to create a…
PHC secures exclusive rights to MaxCyte ExPERT in Japan
The Biomedical Division of PHC Corporation, a subsidiary of PHC Holdings Corporation…
PRD Therapeutics Begins First Human Trial for PRD001
PRD Therapeutics Inc. has announced a first-in-human clinical trial for PRD001. This is…
Axcelead, A2 Healthcare Unite for Pharma R\&D in Japan
Axcelead, Inc., A2 Healthcare Corporation and another company have formed a partnership.…
English